目的 研究尼群地平在大鼠各肠段的吸收动力学特征。方法 采用大鼠在体小肠回流实验装置，利用紫外分光光度法和HPLC分别测定酚红和尼群地平的含量。结果 尼群地平在十二指肠、空肠、回肠、结肠的吸收速率常数分别为0.061 2，0.047 7，0.041 1，0.035 8 h-1；在小肠的吸收速率常数不同药物浓度5，10，15 μg·mL-1时分别为0.101 1，0.108 6，0.108 5 h-1；不同pH值6.4，6.9，7.4，7.9时分别为0.101 0，0.118 5，0.108 6，0.141 7 h-1；增溶剂聚山梨酯80浓度0.3%，0.5%，1.0%时分别为0.107 8，0.108 6，0.102 3 h-1。结论 不同的药物浓度、pH值和聚山梨酯80的浓度对尼群地平在大鼠全肠道的吸收无显著影响，药物的吸收呈一级动力学过程，吸收机制为被动扩散；尼群地平在各肠道均有较好的吸收，提示适于制备日服一次的缓释给药系统。
Abstract
OBJECTIVE To investigate the absorption kinetics of nitrendipine at different intestine segments in rats METHODS The intestine in rats was cannulated for in situ recirculation. UV and HPLC were used to determine the concentrations of phenolsulfonphthalein and nitrendipine, respectively RESULTS The absorption rate constants (Ka) at duodenum, jejunum, ileum, and colon were 0.061?2，0.047 7，0.041 1 and 0.035 8 h-1 respectively. Ka from intestine at nitrendipine concentration of 5, 10, 15 μg·mL-1 were 0.101 1，0.108 6 and 0.108 5 h-1 respectively; Ka at pH of 6.4, 6.9, 7.4 and 7.9 were 0.101 0，0.118 5，0.108 6 and 0.141 7 h-1 respectively; Ka at the concentration of 0.3%，0.5%，1.0% of Tween-80 were 0.107 8，0.108 6 and 0.102?3 h-1 respectively CONCLUSION The concentrations of nitrendipine and Tween-80 and the pH of drug solution had no distinctive effect on the absorption kinetics. The absorption of nitrendipine was a first-order process with passive diffusion mechanism. Nitrendipine was well absorbed at all segments of intestine in rats, which indicate that nitrendipine could be prepared as sustained-release dosage form for administration once a day.
关键词
尼群地平 /
吸收速率常数 /
小肠
{{custom_keyword}} /
Key words
nitrendipine /
absorption rate constant /
intestme
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
［1］Stoepel K, Heise A, Kazeda S. Pharmacological studies of the antihypertensive effect of nitrendipine ［J］.Arzneimittelforsch, 1981,31:2056.
［2］Kazda S, Stasch JP, Hirth C. Nitrendipine in experimental hypertension: effects on cardiac hypertrophy, heart failure, and atrial natriuretic peptides［J］.J Cardiovasc Pharmacol, 1987,9(Suppl 4):S90.
［3］Stewart BH, Chan OH, Jezyk N,et al. Descrimination between drug candidates using models for evaluation of intestinal absorption［J］.Adv Drug Del Rev, 1997,23:275.
［4］Grass GM, Sweetana SA.In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell ［J］.Pharm Res, 1988,5(6):372.
［5］Schurgers N, Bijdendijk J, Tukker JJ. Comparison of four experimental techniques of studying drug absorption kinetics in anesthetized rat in situ［J］.J Pharm Sci, 1986,75(2):117.
［6］Dackson K, Stone JA, Palin KJ. Evaluation of the mass balance assumptin with respect to the tworesistance model of intestinal absorption by using in situ singlepass intestinal perfusion of theophylline in rats ［J］.J Pharm Sci, 1992,81(4):321.
［7］毛凤斐，屠锡德，朱家壁,等. 黄芩甙大鼠小肠吸收的研究［J］. 南京药学院学报, 1984,15(1):61.
［8］陆彬.药剂学实验［M］.北京：人民卫生出版社，1994:131～135.
［9］Janis RA, Krol GJ, Noe AJ,et al. Radioreceptor and highperformance liquid chromatographic assays for the calcium channel antagonist mitrendipine in serum ［J］.J Clin Pharmacol, 1983,23:266.
［10］Krol GJ, Lettieri JT, Yeh SC,et al. Disposition and pharmacokinetics of Cnitrendipine in healthy volunteers ［J］.J Cardiovasc Pharmacol, 1987,9(Suppl 4):S122.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
